Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla

• Peptide endocannabinoids (pepcans) were detected in noradrenergic nuclei and in the chromaffin cells of the adrenal gland.
• Pepcan positive axons were found in projection areas of the locus coeruleus including the cortex, hippocampus, hypothalamus and spinal cord.
• High concentrations of pepcan-12 (RVD-hemopressin) were detected in the mouse adrenal glands (whole organs) using LC-MS/MS.
• Pepcan mAbs are new tools to specifically detect noradrenergic neurons and axons in histological sections where they co-localize with galanin.

The endocannabinoid system (ECS) comprises the cannabinoid receptors CB1 and CB2 and their endogenous arachidonic acid-derived agonists 2-arachidonoyl glycerol and anandamide, which play important neuromodulatory roles. Recently, a novel class of negative allosteric CB1 receptor peptide ligands, hemopressin-like peptides derived from alpha hemoglobin, has been described, with yet unknown origin and function in the CNS. Using monoclonal antibodies we now identified the localization of RVD-hemopressin (pepcan-12) and N-terminally extended peptide endocannabinoids (pepcans) in the CNS and determined their neuronal origin. Immunohistochemical analyses in rodents revealed distinctive and specific staining in major groups of noradrenergic neurons, including the locus coeruleus (LC), A1, A5 and A7 neurons, which appear to be major sites of production/release in the CNS. No staining was detected in dopaminergic neurons. Peptidergic axons were seen throughout the brain (notably hippocampus and cerebral cortex) and spinal cord, indicative of anterograde axonal transport of pepcans. Intriguingly, the chromaffin cells in the adrenal medulla were also strongly stained for pepcans. We found specific co-expression of pepcans with galanin, both in the LC and adrenal gland. Using LC-MS/MS, pepcan-12 was only detected in non-perfused brain (∼40 pmol/g), suggesting that in the CNS it is secreted and present in extracellular compartments. In adrenal glands, significantly more pepcan-12 (400–700 pmol/g) was measured in both non-perfused and perfused tissues. Thus, chromaffin cells may be a major production site of pepcan-12 found in blood. These data uncover important areas of peptide endocannabinoid occurrence with exclusive noradrenergic immunohistochemical staining, opening new doors to investigate their potential physiological function in the ECS.This article is part of the Special Issue entitled ‘Fluorescent Tools in Neuropharmacology’.

Figure optionsDownload as PowerPoint slide